FI771624A7 - - Google Patents

Info

Publication number
FI771624A7
FI771624A7 FI771624A FI771624A FI771624A7 FI 771624 A7 FI771624 A7 FI 771624A7 FI 771624 A FI771624 A FI 771624A FI 771624 A FI771624 A FI 771624A FI 771624 A7 FI771624 A7 FI 771624A7
Authority
FI
Finland
Application number
FI771624A
Other languages
Finnish (fi)
Other versions
FI60501B (fi
FI60501C (fi
Inventor
Edward De Maeyer
Jaqueline De Maeyer-Guignard
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of FI771624A7 publication Critical patent/FI771624A7/fi
Publication of FI60501B publication Critical patent/FI60501B/fi
Application granted granted Critical
Publication of FI60501C publication Critical patent/FI60501C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI771624A 1976-05-21 1977-05-20 Foerfarande foer selektiv separering av interferon fraon interferon-raopreparat FI60501C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7615414A FR2351665A1 (fr) 1976-05-21 1976-05-21 Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
FR7615414 1976-05-21

Publications (3)

Publication Number Publication Date
FI771624A7 true FI771624A7 (https=) 1977-11-22
FI60501B FI60501B (fi) 1981-10-30
FI60501C FI60501C (fi) 1983-06-06

Family

ID=9173478

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771624A FI60501C (fi) 1976-05-21 1977-05-20 Foerfarande foer selektiv separering av interferon fraon interferon-raopreparat

Country Status (6)

Country Link
US (1) US4172071A (https=)
BE (1) BE854916A (https=)
DE (1) DE2722970A1 (https=)
FI (1) FI60501C (https=)
FR (1) FR2351665A1 (https=)
GB (1) GB1585601A (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410697B1 (en) * 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
JPS5651995A (en) * 1979-10-05 1981-05-09 Green Cross Corp:The Preparation of interferon
US4278661A (en) * 1979-10-12 1981-07-14 E. I. Du Pont De Nemours And Company Purification of interferon
US4605394A (en) * 1982-12-03 1986-08-12 Simon V. Skurkovich Methods for the treatment of pathological conditions by removing interferon from the organism
US4362155A (en) * 1981-03-24 1982-12-07 Skurkovich Simon V Method and apparatus for the treatment of autoimmune and allergic diseases
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon
US4658017A (en) * 1984-02-14 1987-04-14 Health Research, Inc. (Roswell Park Division) Method for the large scale purification of human fibroblast interferon
US4803163A (en) * 1984-06-04 1989-02-07 E. I. Du Pont De Nemours And Company Preparation of a protein fraction exhibiting cell growth-inhibiting activity
HU193472B (en) * 1984-09-21 1987-10-28 Vni Sky I Osobo Chistkykh Biop Process for purification of human leucocite interferon
EP0190606B1 (de) * 1985-02-04 1990-05-09 F. Hoffmann-La Roche Ag Adsorbens für die Reinigung von Proteinen
US5144013A (en) * 1986-09-24 1992-09-01 Ube Industries, Ltd. Body fluid purifying material and method for purifying body fluid by use thereof
US5434249A (en) * 1992-05-27 1995-07-18 Viragen Inc. Method for modulating specific activity of inteferon alpha
US20040199099A1 (en) * 1998-07-10 2004-10-07 Matson James R Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US6287516B1 (en) 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
US7291122B2 (en) * 2000-03-24 2007-11-06 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
US6736972B1 (en) 2000-03-24 2004-05-18 Immunocept, L.L.C. Method and system for providing therapeutic agents with hemofiltration for reducing inflammatory mediator related diseases
US6787040B2 (en) 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
WO2002074806A2 (en) 2001-02-27 2002-09-26 Maxygen Aps New interferon beta-like molecules
AU2003255276A1 (en) * 2002-08-13 2004-02-25 Arbios Systems, Inc. Selective plasma exchange therapy
BR112016013876B1 (pt) * 2013-12-27 2022-03-22 Eliaz Therapeutics, Inc. Dispositivo para realização de plasmaferese
CN114041622B (zh) * 2021-10-16 2023-06-27 深圳市真味生物科技有限公司 电子雾化液制备用甜味剂母液脱色的工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB980227A (en) * 1962-08-16 1965-01-13 Glaxo Lab Ltd Purification and/or concentration of material containing interferon
GB1055895A (en) * 1963-12-10 1967-01-18 Glaxo Lab Ltd Interferon purification
US3773924A (en) * 1970-12-24 1973-11-20 M Ho Interferon production
FR2244543B1 (https=) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
CH600782A5 (https=) * 1973-09-10 1978-06-30 Research Corp
US4016149A (en) * 1973-09-10 1977-04-05 Research Corporation Selective removal of albumin from blood fluid and compositions therefore
NL7404589A (nl) * 1974-04-03 1975-10-07 Stichting Rega V Z W Werkwijze voor het stabiliseren van interferon.
US3975344A (en) * 1974-10-02 1976-08-17 G. D. Searle & Co. Interferon purification

Also Published As

Publication number Publication date
FI60501B (fi) 1981-10-30
FR2351665A1 (fr) 1977-12-16
FI60501C (fi) 1983-06-06
GB1585601A (en) 1981-03-11
FR2351665B1 (https=) 1978-12-08
US4172071A (en) 1979-10-23
DE2722970A1 (de) 1977-12-08
BE854916A (fr) 1977-09-16

Similar Documents

Publication Publication Date Title
FR2374933B1 (https=)
DK60277A (https=)
FR2351665B1 (https=)
DE2647505C2 (https=)
DK241377A (https=)
FI53144C (https=)
FR2353291B1 (https=)
JPS52101319U (https=)
JPS5529629Y2 (https=)
FR2346759B3 (https=)
JPS52113839U (https=)
JPS5521892Y2 (https=)
DE2628232C2 (https=)
JPS5313659B2 (https=)
JPS5438358B2 (https=)
JPS5531130B2 (https=)
DK153976A (https=)
JPS5511845Y2 (https=)
JPS5630090B2 (https=)
JPS5355588U (https=)
DK272976A (https=)
JPS52163550U (https=)
JPS5394819U (https=)
DE7604921U1 (https=)
JPS52169608U (https=)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: AGENCE NATIONALE DE VALORISATION DE LA